Clinical Trial Update: Green Tea Extract in Treating Patients With Actinic Keratosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating green tea extract for actinic keratosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Non-melanoma Skin Cancer

Drugs mentioned

• Green Tea Extract (Camellia sinensis extract)

Snippet

Sponsor: Frank Meyskens | Conditions: Non-melanomatous Skin Cancer | Phase 2 | Status: TERMINATED